The global hospital injectable drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to boost the market growth include the rising demand for biologics, rising prevalence of chronic diseases, and the benefits of injectables (convenience, ease of use, and reduced pain). These factors have increased the demand for devices such as safety syringes, prefilled syringes, and autoinjectors, which in turn, is expected to boost the growth of the market. Moreover, as biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to accelerate the market growth in the coming years.
To Request a Sample of our Report on Hospital Injectable Drugs Market: https://www.omrglobal.com/request-sample/hospital-injectable-drugs-market
Over the years, the use of injectable contraceptives has increased significantly. This increased use of injectable contraceptives can mainly be attributed owing to their high efficacy. Injectable contraceptives are not required to be taken daily; they can be administered once every month or once every three months and are considered to be one of the safer modes of pregnancy prevention. They prevent pregnancy 99% of the time, when administered correctly. Owing to these reasons, the demand for contraceptive injectables is expected to drive the market in the future. Furthermore, new launches have been witnessed in the market. For instance, in December 2021, the US FDA approved GSK’s Apretude, or cabotegravir, to reduce the risk of sexually acquired HIV. The endorsement provides users the first long-acting injected option in the pre-exposure prophylaxis (PrEP) setting. With this approval, Apretude will go up against Gilead’s well-established Truvada and its generic, plus the California biotech’s newer Descovy.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Gilead Sciences, Inc., GlaxoSmithKline plc, and Baxter International Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Hospital Injectable Drugs Market is Available @ https://www.omrglobal.com/industry-reports/hospital-injectable-drugs-market
Global Hospital Injectable Drugs Market Report by Segment
By Application
- Cardiology and Metabolic Disorders,
- Oncology
- Neurology
- Gastroenterology
- Pain
- Infectious Diseases
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- E-Commerce
Global Hospital Injectable Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
